Photo Credit: healthland.time.com
A new drug, Belviq, is the first new prescription drug for long-term weight loss to be entered into the U.S. market in over a decade after The Food and Drug Administration approved the Arena Pharmaceutical’s anti-obesity pill.
Although the drug only achieved moderate weight loss during clinical trials, the drug appeared to be safe enough for the FDA to approve and endorse the new pill.
With diabetes or high cholesterol being a medical complication for the new pill, the agency cleared the new medication on Wednesday for adults whom are obese or over weight.
In 2010, the FDA denied approval for the Arena’s drug after scientists raised concerns about tumors that had developed in the animals studied with the drug.
